HEADER TRANSFERASE 24-SEP-08 3EMG TITLE DISCOVERY AND SAR OF NOVEL 4-THIAZOLYL-2-PHENYLAMINOPYRIMIDINES AS TITLE 2 POTENT INHIBITORS OF SPLEEN TYROSINE KINASE (SYK) COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE SYK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN: RESIDUES 349-635; COMPND 5 SYNONYM: SPLEEN TYROSINE KINASE; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 GENE: SYK; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: HIGH-5; SOURCE 8 EXPRESSION_SYSTEM_CELL: INSECT CELLS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PBEV10 TOPO KEYWDS KINASE, SYK, ALTERNATIVE SPLICING, ATP-BINDING, HOST-VIRUS KEYWDS 2 INTERACTION, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, SH2 KEYWDS 3 DOMAIN, TRANSFERASE, TYROSINE-PROTEIN KINASE, UBL CONJUGATION EXPDTA X-RAY DIFFRACTION AUTHOR E.TER HAAR REVDAT 3 03-APR-24 3EMG 1 REMARK REVDAT 2 21-FEB-24 3EMG 1 REMARK SEQADV REVDAT 1 02-DEC-08 3EMG 0 JRNL AUTH L.J.FARMER,G.BEMIS,S.D.BRITT,J.COCHRAN,M.CONNORS, JRNL AUTH 2 E.M.HARRINGTON,T.HOOCK,W.MARKLAND,S.NANTHAKUMAR,P.TASLIMI, JRNL AUTH 3 E.TER HAAR,J.WANG,D.ZHAVERI,F.G.SALITURO JRNL TITL DISCOVERY AND SAR OF NOVEL JRNL TITL 2 4-THIAZOLYL-2-PHENYLAMINOPYRIMIDINES AS POTENT INHIBITORS OF JRNL TITL 3 SPLEEN TYROSINE KINASE (SYK). JRNL REF BIOORG.MED.CHEM.LETT. V. 18 6231 2008 JRNL REFN ISSN 0960-894X JRNL PMID 18938080 JRNL DOI 10.1016/J.BMCL.2008.09.106 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.31 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 8365 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.222 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 12.300 REMARK 3 FREE R VALUE TEST SET COUNT : 1034 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.64 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2610 REMARK 3 BIN FREE R VALUE : 0.3320 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 26 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2081 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 83 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.37 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.09200 REMARK 3 B22 (A**2) : -0.18200 REMARK 3 B33 (A**2) : 0.27400 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.56900 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ANISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 29.87 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : 753685.PAR REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE FRIEDEL PAIRS WERE USED IN PHASING REMARK 4 REMARK 4 3EMG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-OCT-08. REMARK 100 THE DEPOSITION ID IS D_1000049506. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-DEC-03 REMARK 200 TEMPERATURE (KELVIN) : 200 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15406 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 39.305 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.0 REMARK 200 DATA REDUNDANCY : 1.900 REMARK 200 R MERGE (I) : 0.05800 REMARK 200 R SYM (I) : 0.05800 REMARK 200 FOR THE DATA SET : 4.5250 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.9 REMARK 200 DATA REDUNDANCY IN SHELL : 1.80 REMARK 200 R MERGE FOR SHELL (I) : 0.13500 REMARK 200 R SYM FOR SHELL (I) : 0.13500 REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: IN-HOUSE APO STRUCTURE OF SYK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10 MG/ML PROTEIN, 15-20% PEG 8000, 100 REMARK 280 MM SODIUM NITRATE, 100 MM HEPES PH 7.0, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 42.22500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 345 REMARK 465 SER A 346 REMARK 465 LEU A 347 REMARK 465 HIS A 348 REMARK 465 GLU A 349 REMARK 465 SER A 350 REMARK 465 PRO A 351 REMARK 465 TYR A 352 REMARK 465 ALA A 353 REMARK 465 ASP A 354 REMARK 465 PRO A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 ILE A 358 REMARK 465 ARG A 359 REMARK 465 PRO A 360 REMARK 465 LYS A 361 REMARK 465 GLU A 362 REMARK 465 VAL A 363 REMARK 465 TYR A 364 REMARK 465 LYS A 393 REMARK 465 ASN A 406 REMARK 465 GLU A 407 REMARK 465 ALA A 408 REMARK 465 ASN A 409 REMARK 465 ASP A 410 REMARK 465 PRO A 411 REMARK 465 ALA A 412 REMARK 465 GLN A 529 REMARK 465 THR A 530 REMARK 465 HIS A 531 REMARK 465 GLY A 532 REMARK 465 ASP A 632 REMARK 465 VAL A 633 REMARK 465 VAL A 634 REMARK 465 ASN A 635 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LYS A 368 O HOH A 129 1.90 REMARK 500 CG MET A 392 O HOH A 148 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE1 GLN A 391 O HOH A 127 2656 1.86 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 LYS A 548 CD LYS A 548 CE 0.156 REMARK 500 CYS A 593 CB CYS A 593 SG -0.155 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 366 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 ARG A 434 NE - CZ - NH1 ANGL. DEV. = -3.7 DEGREES REMARK 500 GLU A 440 N - CA - C ANGL. DEV. = 18.5 DEGREES REMARK 500 ALA A 441 N - CA - CB ANGL. DEV. = -14.5 DEGREES REMARK 500 ALA A 441 N - CA - C ANGL. DEV. = 34.5 DEGREES REMARK 500 MET A 480 CG - SD - CE ANGL. DEV. = 10.5 DEGREES REMARK 500 LEU A 485 CB - CG - CD1 ANGL. DEV. = -10.3 DEGREES REMARK 500 ARG A 498 NE - CZ - NH1 ANGL. DEV. = -3.9 DEGREES REMARK 500 ARG A 498 NE - CZ - NH2 ANGL. DEV. = 4.0 DEGREES REMARK 500 ARG A 520 NE - CZ - NH1 ANGL. DEV. = -3.1 DEGREES REMARK 500 ASP A 554 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 LEU A 585 CB - CG - CD1 ANGL. DEV. = -11.5 DEGREES REMARK 500 ARG A 590 NE - CZ - NH1 ANGL. DEV. = -3.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 369 44.45 -92.85 REMARK 500 GLU A 440 57.91 -91.86 REMARK 500 ALA A 441 -72.74 -91.94 REMARK 500 ARG A 464 0.95 -62.73 REMARK 500 ARG A 493 -12.30 83.15 REMARK 500 ASP A 494 46.94 -147.84 REMARK 500 LYS A 587 -8.14 -56.33 REMARK 500 TRP A 609 36.05 -92.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LYS A 394 VAL A 395 146.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 685 A 685 DBREF 3EMG A 349 635 UNP P43405 KSYK_HUMAN 349 635 SEQADV 3EMG GLY A 345 UNP P43405 EXPRESSION TAG SEQADV 3EMG SER A 346 UNP P43405 EXPRESSION TAG SEQADV 3EMG LEU A 347 UNP P43405 EXPRESSION TAG SEQADV 3EMG HIS A 348 UNP P43405 EXPRESSION TAG SEQRES 1 A 291 GLY SER LEU HIS GLU SER PRO TYR ALA ASP PRO GLU GLU SEQRES 2 A 291 ILE ARG PRO LYS GLU VAL TYR LEU ASP ARG LYS LEU LEU SEQRES 3 A 291 THR LEU GLU ASP LYS GLU LEU GLY SER GLY ASN PHE GLY SEQRES 4 A 291 THR VAL LYS LYS GLY TYR TYR GLN MET LYS LYS VAL VAL SEQRES 5 A 291 LYS THR VAL ALA VAL LYS ILE LEU LYS ASN GLU ALA ASN SEQRES 6 A 291 ASP PRO ALA LEU LYS ASP GLU LEU LEU ALA GLU ALA ASN SEQRES 7 A 291 VAL MET GLN GLN LEU ASP ASN PRO TYR ILE VAL ARG MET SEQRES 8 A 291 ILE GLY ILE CYS GLU ALA GLU SER TRP MET LEU VAL MET SEQRES 9 A 291 GLU MET ALA GLU LEU GLY PRO LEU ASN LYS TYR LEU GLN SEQRES 10 A 291 GLN ASN ARG HIS VAL LYS ASP LYS ASN ILE ILE GLU LEU SEQRES 11 A 291 VAL HIS GLN VAL SER MET GLY MET LYS TYR LEU GLU GLU SEQRES 12 A 291 SER ASN PHE VAL HIS ARG ASP LEU ALA ALA ARG ASN VAL SEQRES 13 A 291 LEU LEU VAL THR GLN HIS TYR ALA LYS ILE SER ASP PHE SEQRES 14 A 291 GLY LEU SER LYS ALA LEU ARG ALA ASP GLU ASN TYR TYR SEQRES 15 A 291 LYS ALA GLN THR HIS GLY LYS TRP PRO VAL LYS TRP TYR SEQRES 16 A 291 ALA PRO GLU CYS ILE ASN TYR TYR LYS PHE SER SER LYS SEQRES 17 A 291 SER ASP VAL TRP SER PHE GLY VAL LEU MET TRP GLU ALA SEQRES 18 A 291 PHE SER TYR GLY GLN LYS PRO TYR ARG GLY MET LYS GLY SEQRES 19 A 291 SER GLU VAL THR ALA MET LEU GLU LYS GLY GLU ARG MET SEQRES 20 A 291 GLY CYS PRO ALA GLY CYS PRO ARG GLU MET TYR ASP LEU SEQRES 21 A 291 MET ASN LEU CYS TRP THR TYR ASP VAL GLU ASN ARG PRO SEQRES 22 A 291 GLY PHE ALA ALA VAL GLU LEU ARG LEU ARG ASN TYR TYR SEQRES 23 A 291 TYR ASP VAL VAL ASN HET 685 A 685 28 HETNAM 685 2-{2-[(3,5-DIMETHYLPHENYL)AMINO]PYRIMIDIN-4-YL}-N- HETNAM 2 685 [(1S)-2-HYDROXY-1-METHYLETHYL]-4-METHYL-1,3-THIAZOLE- HETNAM 3 685 5-CARBOXAMIDE HETSYN 685 2-{2-[(3,5-DIMETHYLPHENYL)AMINO]PYRIMIDIN-4-YL}-N- HETSYN 2 685 [(2S)-1-HYDROXYPROPAN-2-YL]-4-METHYL-1,3-THIAZOLE-5- HETSYN 3 685 CARBOXAMIDE FORMUL 2 685 C20 H23 N5 O2 S FORMUL 3 HOH *83(H2 O) HELIX 1 1 LEU A 413 GLN A 426 1 14 HELIX 2 2 PRO A 455 GLN A 462 1 8 HELIX 3 3 LYS A 467 SER A 488 1 22 HELIX 4 4 ALA A 496 ARG A 498 5 3 HELIX 5 5 ASP A 512 SER A 516 5 5 HELIX 6 6 PRO A 535 TYR A 539 5 5 HELIX 7 7 ALA A 540 TYR A 546 1 7 HELIX 8 8 SER A 551 SER A 567 1 17 HELIX 9 9 LYS A 577 LYS A 587 1 11 HELIX 10 10 PRO A 598 TRP A 609 1 12 HELIX 11 11 GLY A 618 TYR A 631 1 14 SHEET 1 A 3 LEU A 370 LEU A 372 0 SHEET 2 A 3 GLY A 383 GLN A 391 -1 O TYR A 389 N THR A 371 SHEET 3 A 3 GLY A 378 SER A 379 -1 N GLY A 378 O VAL A 385 SHEET 1 B 5 LEU A 370 LEU A 372 0 SHEET 2 B 5 GLY A 383 GLN A 391 -1 O TYR A 389 N THR A 371 SHEET 3 B 5 VAL A 396 LEU A 404 -1 O LYS A 397 N TYR A 390 SHEET 4 B 5 TRP A 444 GLU A 449 -1 O LEU A 446 N LYS A 402 SHEET 5 B 5 MET A 435 GLU A 440 -1 N CYS A 439 O MET A 445 SHEET 1 C 2 PHE A 490 VAL A 491 0 SHEET 2 C 2 LYS A 517 ALA A 518 -1 O LYS A 517 N VAL A 491 SHEET 1 D 2 VAL A 500 THR A 504 0 SHEET 2 D 2 TYR A 507 ILE A 510 -1 O TYR A 507 N VAL A 503 SHEET 1 E 2 TYR A 525 LYS A 527 0 SHEET 2 E 2 LYS A 548 SER A 550 -1 O PHE A 549 N TYR A 526 CISPEP 1 LYS A 533 TRP A 534 0 -8.24 SITE 1 AC1 13 LEU A 377 SER A 379 PHE A 382 VAL A 385 SITE 2 AC1 13 ALA A 400 LYS A 402 MET A 448 GLU A 449 SITE 3 AC1 13 MET A 450 ALA A 451 GLY A 454 LEU A 501 SITE 4 AC1 13 ASP A 512 CRYST1 39.870 84.450 41.440 90.00 99.63 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025082 0.000000 0.004256 0.00000 SCALE2 0.000000 0.011841 0.000000 0.00000 SCALE3 0.000000 0.000000 0.024476 0.00000